Prague, Czechia

Ivan Rosenberg


Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 319(Granted Patents)


Location History:

  • Obrancu min, CZ (1988)
  • Praha, CZ (1989 - 1992)
  • Prague, CZ (1987 - 1999)

Company Filing History:


Years Active: 1987-1999

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Ivan Rosenberg: Innovator in Nucleotide Analogues

Introduction

Ivan Rosenberg is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of nucleotide analogues, with a total of 6 patents to his name. His work focuses on developing biologically active compounds that have potential applications in antiviral therapies.

Latest Patents

Among his latest patents is the invention of 9-(2-phosphonylmethoxyethyl) guanine. This invention addresses the technical problem of utilizing new nucleotide analogues as biologically active compounds. The subject of this patent includes N-(2-phosphonylmethoxyethyl) and N-(3-hydroxy-2-phosphonylmethoxypropyl) derivatives of pyrimidine and purine bases. These derivatives are easily accessible from heterocyclic bases and their N-(2-hydroxyethyl) or N-(2,3-dihydroxypropyl) derivatives. Some of the compounds described in this invention exhibit marked antiviral activity or can be transformed into active compounds through chemical processes.

Career Highlights

Ivan Rosenberg has worked with prestigious institutions such as the Czech Academy of Sciences and the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences. His research has significantly advanced the understanding and application of nucleotide analogues in medicinal chemistry.

Collaborations

Throughout his career, Ivan has collaborated with esteemed colleagues, including Antonin Holy and Erik D De Clercq. These collaborations have further enriched his research and contributed to the development of innovative solutions in his field.

Conclusion

Ivan Rosenberg's contributions to the field of nucleotide analogues highlight his role as a key innovator in the scientific community. His patents and collaborations reflect a commitment to advancing antiviral therapies through innovative research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…